MYIA
IDXX icon

Mount Yale Investment Advisors’s Idexx Laboratories IDXX Stock Holding History

Mount Yale Investment Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$925K Buy
1,758
+49
+3% +$27.5K 0.02% 603
2026
Q1 		$960K Buy
1,709
+841
+97% +$539K 0.02% 530
2025
Q4 		$587K Buy
868
+344
+66% +$234K 0.03% 423
2025
Q3 		$335K Buy
524
+457
+682% +$277K 0.02% 499
2025
Q2 		$35.9K Buy
+67
New +$32K ﹤0.01% 905

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Mount Yale Investment Advisors's IDXX Position: Q2 2026 in Review

Mount Yale Investment Advisors increased its Idexx Laboratories (IDXX) stake by 2.9% in Q2 2026, buying an estimated $27.5K and bringing the position to 1,758 shares worth $925K. The position accounts for 0.02% of the portfolio, ranked #603.

Mount Yale Investment Advisors first reported a position in IDXX in Q2 2025 and has held it in 5 quarters since. The position peaked at $960K in Q1 2026. 1,306 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Mount Yale Investment Advisors held 1,758 shares of Idexx Laboratories worth $925K as of Q2 2026.
  • Mount Yale Investment Advisors bought 49 Idexx Laboratories shares in Q2 2026, an estimated $27.5K.
  • Idexx Laboratories made up 0.02% of Mount Yale Investment Advisors's portfolio in Q2 2026, its #603 holding.
  • Mount Yale Investment Advisors first reported a position in Idexx Laboratories in Q2 2025 and has held it in 5 quarters since.
  • Mount Yale Investment Advisors's Idexx Laboratories position peaked at $960K in Q1 2026.
  • 1,306 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Mount Yale Investment Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.